SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.59-0.9%Oct 30 4:00 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (1464)2/19/2007 8:23:09 AM
From: finbar  Read Replies (1) of 1475
 
FWIW - there a reason that BTRN still trades around a nickel+
While there are no employees or active business, they still own a chunk of Stem Cell Sciences stock which now publicly trades on the AIM in London, more importantly they still have retained milestone and royalty rights for Medi-507 which Medimmune is advancing through trials, and for which they have reported very favorable results to date. A liquidator files status reports a few times a year in the bk court for Mass.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News